Rallybio Corp旗下Candid完成超额认购私募融资 总收益突破5.05亿美元

美股速递
Mar 02

生物技术公司Rallybio Corp宣布,其关联企业Candid成功完成一轮超额认购且规模扩大的私募融资。本轮融资总收益超过5.05亿美元,反映出市场对该公司发展前景的强烈信心。

此次融资获得超额认购,最终规模较原计划有所上调。资金的注入将助力Candid加速推进其创新疗法研发进程,为未来业务拓展提供坚实支撑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10